Hodgkin’s Lymphoma Information Center
Knowledge is power. Are you facing a new diagnosis, recurrence, living with metastatic disease, or supporting a loved one through their cancer journey? The Cancer Connect Hodgkin’s Lymphoma Information Center has current, evidence-based information for you. Get the facts about Hodgkin’s lymphoma prevention, early detection, treatment, and survivorship, and stay up to date with ongoing Hodgkin’s lymphoma research that could impact your treatment decisions through our daily cancer news.
You are not alone—The CancerConnect Hodgkin’s Lymphoma Community is the leading Social Media Application for Hodgkin’s Lymphoma patients and caregivers seeking information, inspiration, and support in the wake of a cancer diagnosis. With over 50,000 members the network offers patients and caregivers a thriving community to support the many ongoing needs from diagnosis to survivorship. Login or register here.
Rituxan is active in nodular lymphocyte–predominant Hodgkin lymphoma. Adcetris and PET-Adapted Salvage Therapy Effective in Relapsed/Refractory Hodgkin’s Lymphoma
Patients with relapsed/refractory Hodgkin’s lymphoma who achieve complete responses after treatment with Adcetris can skip more toxic salvage therapy and proceed straight to transplant. Adcetris Improves Response Rates to ABVD in Hodgkin’s Lymphoma
Adding Adcetris to ABVD produces high response rate in advanced Hodgkin’s lymphoma.
Cancer and its treatment can come with a variety of complications, some more serious... Advanced Directives
Living Wills Every competent adult has, in most cases, the freedom to accept or refuse... Caregivers
What is Caregiving and Who are Caregivers? Caregivers are individuals who provide...
Hodgkin’s Lymphoma Management
Sean Swarner is a master of setting a goal and achieving it. So when he... Jack & Jill Late Stage Cancer Foundation
Jon Albert, founder of the Jack & Jill Late Stage Cancer Foundation shows the... Moving Bodies, Changing Lives
Moving On Aerobics helps women regain joy of movement and physical fitness after...
Hodgkin’s Lymphoma Clinical Trials
COGAHOD0431 – Phase III Study for the Treatment of Children and Adolescents with Newly Diagnosed Low-Risk Hodgkin Disease
COGAHOD03P1 – Treatment of Children with Newly-Diagnosed Low Stage Lymphocyte Predominant Hodgkin Disease
COGAHOD04B1 – Hodgkin Disease (HD) Banking Study.